90 results on '"Kozma, Sara C."'
Search Results
2. Data from Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
3. Supplementary Fig. S1 from Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
4. Data from Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR
5. Data from Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content
6. Suppl.Mat., Suppl. Table, Suppl. Figs Legends from Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR
7. Supplementary Data S1-S5, Table from Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content
8. Data from Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
9. Suppl.Mat., Suppl. Table, Suppl. Figs Legends from Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR
10. Supplementary Fig. S1 from Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
11. Supplementary Data S1-S5, Table from Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content
12. Data from Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis
13. Supplementary Figures 1-4 from Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis
14. Data from Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis
15. A compound directed against S6K1 hampers fat mass expansion and mitigates diet-induced hepatosteatosis
16. The PI3K-mTOR Pathway
17. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death
18. Targeting mTOR Signaling Pathways in Liver Disease
19. Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage
20. S6K
21. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content
22. Mitochondrial Complex I Activity Is Required for Maximal Autophagy
23. Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR
24. Autogenous Control of 5′TOP mRNA Stability by 40S Ribosomes
25. A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
26. EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice
27. S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis
28. S6K-STING interaction regulates cytosolic DNA–mediated activation of the transcription factor IRF3
29. Effect of low doses of actinomycin D on neuroblastoma cell lines
30. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells
31. V-ATPase: a master effector of E2F1-mediated lysosomal trafficking, mTORC1 activation and autophagy
32. A liaison between mTOR signaling, ribosome biogenesis and cancer
33. S6K1 controls pancreatic β cell size independently of intrauterine growth restriction
34. Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection
35. INSULIN MEDIATED S6 KINASE ACTIVATION
36. Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth
37. Rapamycin impacts positively on longevity, despite glucose intolerance induction
38. mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma
39. Metabolic Control by S6 Kinases Depends on Dietary Lipids
40. A guide to analysis of mouse energy metabolism
41. Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis
42. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage
43. Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
44. mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
45. The Nuclear Receptor DHR3 Modulates dS6 Kinase–Dependent Growth in Drosophila
46. Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
47. S6K1 Plays a Critical Role in Early Adipocyte Differentiation
48. Abstract 5349: Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type-I IFN production
49. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
50. Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.